Re: Kimmo Kettunen, Peter J. Boström, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4
- PMID: 31420251
- DOI: 10.1016/j.eururo.2019.07.044
Re: Kimmo Kettunen, Peter J. Boström, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4
Comment in
-
Reply to Mengxin Lu, Yi Zhang, Yu Xiao's Letter to the Editor, re: Kimmo Kettunen, Peter J. Boström, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4.Eur Urol. 2019 Nov;76(5):e137-e138. doi: 10.1016/j.eururo.2019.07.049. Epub 2019 Aug 13. Eur Urol. 2019. PMID: 31420250 No abstract available.
Comment on
-
Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells.Eur Urol. 2019 Oct;76(4):430-434. doi: 10.1016/j.eururo.2019.06.016. Epub 2019 Jun 28. Eur Urol. 2019. PMID: 31256944
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
